INTRODUCTION

A dedicated unit of the new facility was designed for the purpose of producing bulk drug intermediates. Our core competence in this area is in the production of -Lactam intermediates, which are used to produce a number of antibiotics.

The current range of intermediates includes:
• 6-Aminopenicillanic acid (6APA)
• 7-Aminodeacetoxycephalosporanic acid (7ADCA)
• 7-Aminocephalosporanic acid (7ACA)

Great care is taken in the production process of each product, from start to finish, so as to maintain the product's yield and purity. We are able to implement this strategy via our four stage testing process, which encompasses the following:

1. Raw material testing and approval
2. Validation of production machinery
3. In process testing
4. Final product analysis

Each product has a dedicated team, which aids in the improvement of our processes and products, and is a measure of our intention to provide the right quality material in the right amount of time.



PRODUCTS

6-Aminopenicillanic Acid (6APA)
6APA is a well-known key intermediate, used in the production of semi synthetic penicillins, which include:

• Amoxicillin
• Ampicillin
• Cloxacillin
• Dicloxacillin
• Flucloxacillin

7ADCA and 7ACA

Our intermediate range has recently been increased to encompass 7ADCA and 7ACA, both produced via the enzymatic routes.

7ADCA itself is key intermediate for the production of:

• Cephalexin
• Cephadroxil
• Cefradine
• Cefroxadine

7ACA is a key intermediate for the production of a major part of the Cephalosporins range, which includes:

• Cefazolin
• Ceftriaxone
• Cefotaxime
• Cefuroxime
• Cefixime
• Cefotetan

Further technical details can be found on our specifications page. Should you require any additional information, please feel free to contact us on info@dalasbiotech.com




SPECIFICATIONS

6 APA